Liver fibrosis: cellular mechanisms of progression and resolution
The DOI matches its Crossref record; 137 of the 139 references it cites were found in a registry or an index.
Abstract
Liver fibrosis represents a major worldwide health care burden. The last 15 years have seen a rapid growth in our understanding of the pathogenesis of this clinically relevant model of inflammation and repair. This work is likely to inform the design of effective antifibrotic therapies in the near future. In this review, we examine how the innate and adaptive immune response interacts with other key cell types in the liver, such as the myofibroblast, regulating the process of hepatic fibrosis and, where relevant, resolution of fibrosis with remodelling. Emphasis is placed on the increasing knowledge that has been generated by the use of transgenic animals and animals in which specific cell lines have been deleted. Additionally, we review the increasing evidence that, although significant numbers of wound-healing myofibroblasts are derived from the hepatic stellate cell, significant contributions may occur from other cell lineages, including those from distant sites such as bone marrow stem cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, liver fibrosis is now recognized as a potentially reversible process, with resolution being closely linked to the reprogramming of macrophages towards restorative phenotypes characterized by enhanced efferocytosis, reduced pro-inflammatory signaling, and increased matrix degradation capacity.”
From Targeting macrophages in liver fibrosis (2026) · cites this paper as [88]
In the citing paper
“Resolution of fibrosis involves not only the degradation of ECM but also reprogramming of the immune microenvironment (87, 88).”
From Targeting macrophages in liver fibrosis (2026) · cites this paper as [88]
In the citing paper
“Fibrosis is regulated by an intricate interplay between TGF‐β pro‐fibrotic and TNF‐α anti‐fibrotic signaling pathways”
From p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling (2017) · cites this paper as Henderson & Iredale, 2007
Citations
Cites
1 retracted
RETRACTED: TGF-β1 induces alveolar epithelial to mesenchymal transition in vitro
Yao, H.-W., Xie, Q.-M., Chen, J., Deng, Y., & Tang, H. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.019 · Cited by 109
RetractedAlternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · cited 1×
“Duffield et al. (2005) [4]”
Self-citationEvidence that fibroblasts derive from epithelium during tissue fibrosis
Iwano, M., Plieth, D., Danoff, T. M., Xue, C., Okada, H., & Neilson, E. G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215518 · Cited by 1,590
The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum.
(1975) · PubMed Central · Cited by 1,437
Zeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
Cited by
Items 201–270 of 270
Markowitz, G. J., Michelotti, G. A., Diehl, A. M., & Wang, X.-F. (2015) · 中国科学通报:英文版 · doi:10.1007/s11434-015-0772-5 · Cited by 7
Nam, T.-H., Park, B. J., Sung, D. J., Kim, M. J., Han, N., Sim, K. C., Lee, J. H., & Cho, S. B. (2015) · Abdominal Radiology · doi:10.1007/s00261-015-0597-3 · Cited by 7
Persistent activation of omentum influences the pattern of muscular lesion in the mdx diaphragm
Pinheiro, D. F., da Silva, R. F., Carvalho, L. F. P. P. D. C., Paiva-Oliveira, E. L., Pereira, R. S., Leite, P. E. C., Pinho, M. D. F., Quírico‐Santos, T., & Lagrota-Cândido, J. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1443-3 · Cited by 7
Wang, Y., Dong, J., Meng, W., Ma, J., Wang, N., Wei, J., & Shi, M. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1662 · Cited by 7
Aspectos moleculares de la encefalopatía hepática
Márquez-Aguirre, A. L., Canales-Aguirre, A. A., Gómez‐Pinedo, U., & Gálvez-Gastélum, F. J. (2010) · Neurología · doi:10.1016/j.nrl.2009.12.001 · Cited by 7
Zhang, M., Wang, F., Chong, Y., Tai, Q., Zhao, Q., Zheng, Y., Peng, L., Lin, S., & Gao, Z. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0308-9 · Cited by 9
Standing Down the Guard: Stellate Cells Leave Quietly
Henderson, N. C., & Iredale, J. P. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.014 · Cited by 7
Self-citationZeng, R., Liu, S., Ye, T., Xu, W., Huang, K., Qiu, F., Liu, C., & Hu, X. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120074 · Cited by 9
Combinatorial gene therapy renders increased survival in cirrhotic rats
Gálvez-Gastélum, F. J., Segura-Flores, A. A., Senties-Gomez, M. D., Muñóz-Valle, J. F., & Armendáriz‐Borunda, J. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-42 · Cited by 8
Elsayed, H. R. H., Abd-Elmonem, M. M., Gabr, O., & Badria, F.-E. (2015) · Benha Medical Journal · doi:10.4103/1110-208x.180324 · Cited by 7
Adverse Outcome Pathway on Protein Alkylation Leading to Liver Fibrosis
Landesmann, B. (2016) · OECD series on adverse outcome pathways · doi:10.1787/5jlsvwl6g7r5-en · Cited by 9
[Corrigendum] Influencing factors of transient elastography in detecting liver stiffness
Shan, R., Yin, H. X., Yang, W., Li, J., Zhang, M., Zhao, M., Shao, J., & Wang, A. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6864 · Cited by 6
Carballo-López, G. I., Ojeda-González, J., Martínez-García, K. D., Cervantes-Luévano, K., Moreno‐Ulloa, A., & Castro-Ceseña, A. B. (2024) · Molecular Omics · doi:10.1039/d4mo00195h · Cited by 6
García-Topete, D. A., Álvarez-Lee, L., Carballo-López, G. I., Uriostegui-Campos, M. A., Guzmán-Uribe, C., & Castro-Ceseña, A. B. (2024) · Biomaterials Science · doi:10.1039/d3bm01710a · Cited by 6
LncRNA MALAT1: A Potential Fibrosis Biomarker and Therapeutic Target
Li, Y., Liu, F., Cai, Y., Yang, Y., & Wang, Y. (2021) · Crystals · doi:10.3390/cryst11030249 · Cited by 5
Role of Cytokines in Liver Fibrosis
Anapalı, M., & Balkan, E. (2021) · Kafkas Journal of Medical Sciences · doi:10.5505/kjms.2021.75537 · Cited by 6
Gandhi, C. R. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_5 · Cited by 5
Zeng, R., Guo, Y., Qi, J., Li, M., Huang, K., Peng, Y., Li, Z., & Liu, C. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120650 · Cited by 6
TET1 inhibits liver fibrosis by blocking hepatic stellate cell activation
Wang, J., Zhang, Y., Ma, Y., Zhao, S., Wang, J., Chen, H., Zhang, J., & Liu, J. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16443 · Cited by 5
Scar formation and lack of regeneration in adult and neonatal liver after stromal injury
Masuzaki, R., Zhao, S. R., Csizmadia, E., Yannas, I. V., & Karp, S. J. (2012) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2012.00868.x · Cited by 4
Tobolowsky, F. A., Wada, N., Martinez-Maza, O., Magpantay, L. I., Koletar, S. L., Palella, F. J., Brown, T. T., & Lake, J. E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191606 · Cited by 4
СТЕАТОЗ І СТЕАТОГЕПАТИТ — ТРИГЕРИ ПЕЧІНКОВОГО ФІБРОГЕНЕЗУ?
Stepanov, Y. М., & Filippova, A. Y. (2013) · GASTROENTEROLOGY · doi:10.22141/2308-2097.2.48.2013.86164 · Cited by 4
Wanless, I. R. (2011) · Wiley eBooks · doi:10.1002/9781119950509.ch5 · Cited by 4
Targeting macrophages in liver fibrosis
González del Barrio, L., Ipsen, D. H., Pfister, D. R., Hancz, D., & Scott, C. L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835489 · Cited by 3
Unveiling the role of Pafah1b3 in liver fibrosis: A novel mechanism revealed
Lin, L., Yang, S., Li, X., Zhang, W., & Zheng, J. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101158 · Cited by 3
Sreedhar, H., Pant, M., Ronquillo, N. R., Davidson, B., Nguyen, P. L., Chennuri, R., Choi, J. J., Herrera, J. A., Hinojosa, A. C., Jin, M. L., et al. (2014) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2040408 · Cited by 3
Maternal Undernutrition and Long-Term Effects on Hepatic Function
Hardy, D. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-60289-9_9 · Cited by 4
Nimbalkar, V., Shelke, R. P., Kadu, U. E., & Gaikwad, P. M. (2018) · International Journal of Clinical and Biomedical Research · doi:10.31878/ijcbr.2018.43.11 · Cited by 4
Computer‐Aided Diagnosis of Liver Fibrosis in Hepatitis Patients Using Convolutional Neural Network
Aswathy, S. U., Ajesh, F., Shamsudheen, S., & Jarin, T. (2021) · Wiley eBooks · doi:10.1002/9781119785750.ch9 · Cited by 3
Chae, Y.-J., Koppula, S., Kim, M.-K., Yoon, T., & Song, M.-D. (2021) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/2221-1691.328057 · Cited by 2
Vascular Disorders of the Liver
Wanless, I. R. (2011) · Elsevier eBooks · doi:10.1016/b978-0-443-06803-4.00032-0 · Cited by 2
Targeting RNA Polymerase I Inhibits Ribosome Biogenesis to Block Liver Fibrosis Progression
Luo, W., Yi, L., Zhang, Y., Zhou, J., Li, S., Abouelnazar, F. A., Wang, Y., & Yan, Y. (2025) · Liver International · doi:10.1111/liv.70478 · Cited by 1
Correlation Between Thrombin Generation and Hepatic Fibrosis in Chronic Liver Diseases
Vecerzan, L., Maniu, I., & Cioca, G. (2024) · Cureus · doi:10.7759/cureus.71376 · Cited by 1
Balta, A. A. Ș., Barbu, R. E., Baroiu, L., Bulza, V., Bujoreanu, F. C., Moroianu, M., Ignat, M. D., Cambrea, S. C., Dumea, E., & Stoian, V. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14228112 · Cited by 2
Perfil de un judeoconverso del Reino de Granada: el escribano Antón López de Toledo
Beltrán, M. T. (2006) · Revista del Centro de Estudios Históricos de Granada y su Reino/Revista del Centro de Estudios Históricos de Granada y su Reino · Cited by 6
Dancygier, H., & Schirmacher, P. (2009) · Springer eBooks · doi:10.1007/978-3-540-93842-2_28 · Cited by 1
Biochemical study on Emodin and silymarin as a treatment for ccl4- induced hepatic fibrosis in mice.
Zein, N., Saad, M., & Amer, A. (2023) · Bulletin of Faculty of Science Zagazig University · doi:10.21608/bfszu.2022.153579.1161 · Cited by 1
Hepatic Myofibroblasts in Liver Fibrogenesis
Busletta, C., Novo, E., Cannito, S., Paternostro, C., & Parol, M. (2012) · InTech eBooks · doi:10.5772/29287 · Cited by 1
Emerging drugs for complications of end-stage liver disease
Dowman, J. K., Holt, A. P., Newsome, P. N., & Adams, D. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.1.159 · Cited by 1
Kim, J. S., Koppula, S., Yum, M. J., Shin, G. M., Chae, Y. J., Kopalli, S. R., & Song, M. (2020) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.627 · Cited by 1
Stellate Cell Depletion Models
Oakley, F., & Mann, D. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00015-4 · Cited by 2
Friedman, S. L. (2011) · Wiley eBooks · doi:10.1002/9781119950509.ch12 · Cited by 1
Friedman, S. L. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch10 · Cited by 1
Role of Kupffer cells in hepatic fibrosis
Zhao, C., & Dai, C. (2008) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v16.i26.2959
Mazo, D. F. D. C. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2012.tde-05042012-093828
Innate Immunity in Alcohol Liver Disease
Soares, J.-B., & Pimentel‐Nunes, P. (2012) · InTech eBooks · doi:10.5772/26821 · Cited by 1
Lima, T. C. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2008.tde-09012009-091225
Fisiopatologia de la cèl·lula endotelial en la cirrosi hepàtica
Tugues, S. (2008) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Mechanistic behaviour and molecular interactions of heat shock protein 47 (HSP47)
Abdul Wahab, M. F. (2011) · doi:10.25560/9208
Keerthana, R., Kumaravel, M., Raviteja, M., & Rajagopalan, R. (2012) · Journal of Pharmacy Research
Gálvez-Gastélum, F. J., Segura-Flores, A. A., Senties-Gomez, M. D., & Armendáriz‐Borunda, J. (2010)
Hepatic stellate cell transdifferentiation: Pro-fibrogenic effectors
Lakner, A. M., & NC DOCKS at The University of North Carolina at Charlotte (2011) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)
State-of-the-Art Lecture: Mechanisms of liver fibrosis — targets for therapy
Gordon‐Walker, T. T., Pellicoro, A., & Iredale, J. P. (2009) · Springer eBooks · doi:10.1007/978-90-481-2759-7_15
Self-citationThe role of the coagulation system in the pathogenesis of liver injury
Dhar, A. (2011) · doi:10.25560/9479 · Cited by 1
Ivanov, A. S., Гармаш, И. В., Сергеевна, А. О., Маркова, М. А., Melnik, A. S., Terebilina, N. N., Баронец, В. Ю., Peregud, D., Tarasenko, E. V., & Kobalava, Z. D. (2018) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn1059
Al-Hameary, Y. D. H., Eesa, M. J., & Al-Harbawy, R. M. A. (2013) · Al-Anbar Journal of Veterinary Sciences
Hashim, Y., Abdel Baky, N., Kamal, M., & Gad, A. (2021) · Azhar International Journal of Pharmaceutical and Medical Sciences · doi:10.21608/aijpms.2021.54231.1028
Mesenchymal stromal cell therapy for liver fibrosis
Haldar, D. (2019) · University of Birmingham Institutional Research Archive (University of Birmingham)
Hussain, Z., Rashid, H., Mushtaq, A., Siddique, R., & Ali, A. (2022) · Journal of Life Sciences Research · doi:10.20448/journal.504.2021.81.1.9
Navin, P. J., Venkatesh, S. K., & Ehman, R. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00058-2
Current concept of hepatic fibrogenesis in mouse models of liver fibrosis
Scholten, D., & Brenner, D. A. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8656-4_12
Miao, L., Cao, L., & Wang, G. (2023) · Central European Journal of Immunology · doi:10.5114/ceji.2023.127621 · Cited by 1
Galal, S. M., Mostafa, D. M., & kiki, S. M. E. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04287-5
Zearalenone Promotes Hepatic Stellate Cell Activation and Early Profibrotic Tendency in the Liver
Bao, L., Huang, Y., Bao, J., Lu, Y., Chen, C., Wu, Z., & Li, J. (2026) · Biomolecules · doi:10.3390/biom16050644
Momordica charantia Attenuates Hepatic Steatosis in High‐Fat, High‐Sucrose Diet‐Induced Obese Mice
Woo, H.-M., Park, S.-Y., Jo, Y.-H., Lee, S.-J., Yeon, S. H., Han, H.-S., Yi, T., Kim, Y., Kim, Y.-M., & Bae, H. (2026) · Analytical Cellular Pathology · doi:10.1155/ancp/2235628
Moon, H., Park, H., Lee, C. H., Kim, H. J., Oh, J., Choi, J. U., Na, J. H., & Lee, S. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115987
Metadata
- Authors
- Henderson, N. C., & Iredale, J. P.
- Affiliations
- Centre for Inflammation Research (GB)
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2007-02-01
- Volume
- 112
- Issue
- 5
- Pages
- 265-280
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W1976809932
- Cited by
- 270
- References
- 139
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 6 · 2022: 3 · 2021: 15 · 2020: 11 · 2019: 10 · 2018: 15 · 2017: 13 · 2016: 23 · 2015: 25 · 2014: 19 · 2013: 15 · 2012: 20
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Medical Research Council
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- liver fibrosis, fibrosis resolution, myofibroblasts, hepatic stellate cells, wound healing, innate immune response, adaptive immune response, antifibrotic therapy, transgenic animal models, lineage tracing, bone marrow-derived stem cells, liver regeneration
- MeSH terms
- Animals, Disease Models, Animal, Fibroblasts, Humans, Immunity, Cellular, Liver Cirrhosis, Prognosis, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.